Global Central Lab Market Report 2022: Rising Number of Clinical Trials, and the Increased Use of Intelligent Technologies Like Automation and Artificial Intelligence Driving Growth - ResearchAndMarkets.com

DUBLIN--()--The "Central Lab Market Analysis, by Product, by End-user, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The central lab market size is estimated to be USD 2,893.41 million in 2021 and is expected to witness a CAGR of 6.74% during the forecast period 2022-2029. The rising number of clinical trials, and the increased use of intelligent technologies like automation and artificial intelligence (AI) in central labs are projected to drive the market growth in near future. However, high operating costs associated with a central laboratory facility is expected to restrain the market growth.

By Product

Based on product, the market is categorized into biomarker services, special chemistry services, clinical research & trial services, genetic services, anatomic pathology/histology, microbiology services, specimen management & storage, and others. In 2021, the biomarker services accounted for the highest revenue share due to increasing use of biomarkers in clinical development programmes.

By End User

On the basis of product, the market is categorized into academic research institute, biotechnology companies, and pharmaceutical companies. In the global market, the pharmaceutical companies segment accounted for the largest revenue share in 2021 owing to rising demand from biotechnology and pharmaceutical industries for efficient and affordable clinical testing solutions and various central lab services.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product and end user from 2021 to 2029.

Segmentation: Central Lab Market Report 2021-2029Product (Revenue, USD Million)

  • Biomarker Services
  • Special Chemistry Services
  • Clinical Research & Trial Services
  • Genetic Services
  • Anatomic Pathology/Histology
  • Microbiology Services
  • Specimen Management & Storage
  • Others

End user (Revenue, USD Million)

  • Academic Research Institute
  • Biotechnology Companies
  • Pharmaceutical Companies

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Key Topics Covered:

1. Research Methodology

2. Introduction: Central Lab

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Central Lab Market

7. Market Analysis by Product

8. Market Analysis by End User

9. Regional Market Analysis

10. North America Central Lab Market

11. Europe Central Lab Market

12. Asia Pacific Central Lab Market

13. Latin America Central Lab Market

14. MEA Central Lab Market

15. Competitor Analysis

16. Company Profiles

17. Conclusion & Recommendations

Companies Mentioned

  • Agilent Technologies (US)
  • Bio-Rad Laboratories Inc. (US)
  • Danaher Corporation (US)
  • Siemens Heathineers (Germany)
  • Eppendorf AG (Germany)
  • Thermo Fisher Scientific Inc. (US)
  • PerkinElmer Inc. (US)
  • Pace Analytical Services Inc. (US)
  • Waters Corporation (US)
  • Becton
  • Dickinson and Company (US).

For more information about this report visit https://www.researchandmarkets.com/r/9ux9go

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900